FDA-Approved RENFLEXIS for Treatment of Multiple Autoimmune Diseases Now Distributed by BioCareSD
TEMPE, ARIZONA, UNITED STATES, February 8, 2024 /EINPresswire.com/ -- BioCareSD, a leading specialty distributor for orphan, rare and ultra-rare diseases, announced today that they have added RENFLEXIS, a biosimilar to REMICADE, to their ever- …